Delayed respiratory arrest after epidural hydromorphone.

Area of Science:

• Anesthesiology
• Pharmacology
• Critical Care Medicine

Background:

• Epidural analgesia is commonly used for pain management.
• Opioids are frequently administered via the epidural route.
• Understanding the pharmacokinetic and pharmacodynamic profile of epidural opioids is crucial for patient safety.

Observation:

• A case of delayed apnoea following epidural hydromorphone administration is reported.
• The patient received 1 mg of hydromorphone in the epidural space.
• No other opioid analgesics were administered within 10 hours prior to the event.

Findings:

• Epidural hydromorphone, even at a low dose of 1 mg, can lead to significant respiratory depression.
• The onset of apnoea was delayed, occurring 4.5 hours after injection.
• This suggests a prolonged duration of action or delayed systemic absorption of epidural hydromorphone.

Implications:

• Clinicians should be vigilant for delayed respiratory depression in patients receiving epidural hydromorphone.
• Extended monitoring may be necessary after epidural opioid administration.
• This case underscores the importance of considering the route and dose of opioid administration when assessing respiratory risk.